OPERATING AND REPORTABLE SEGMENTS

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

OPERATING AND REPORTABLE SEGMENTS

The Company's operating and reportable segments, “Infusion Services," "Home Health Services” and “PBM Services,” reflect how the Company's chief operating decision maker reviews the Company's results in terms of allocating resources and assessing performance.

The Infusion Services operating and reportable segment provides services consisting of home infusion therapy, respiratory therapy and the provision of durable medical equipment, products and services. Infusion services include the dispensing and administering of infusion-based drugs, which typically require additional nursing and clinical management services, equipment to administer the correct dosage and patient training designed to improve patient outcomes. Home infusion services also include the dispensing of self-injectable therapies.

The Home Health Services operating and reportable segment provides services including the provision of skilled nursing services and therapy visits, private duty nursing services, hospice services, rehabilitation services and medical social services to patients primarily in their home.

The PBM Services operating and reportable segment consists of integrated pharmacy benefit management ("PBM") services, which primarily consists of discount card programs. The discount card programs provide a cost effective alternative for individuals who may be uninsured, underinsured or may have restrictive coverage that disallows reimbursement for certain medications. Under these discount programs, individuals who present a discount card at any of the Company's participating network pharmacies receive prescription medications at a discounted price compared to the retail price.

The Company's chief operating decision maker evaluates segment performance and allocates resources based on Segment Adjusted EBITDA. Segment Adjusted EBITDA is defined as income (loss) from continuing operations, net of income taxes adjusted for net interest expense, income tax expense (benefit), depreciation, amortization of intangibles and stock-based compensation expense and prior to the allocation of certain corporate expenses. Segment Adjusted EBITDA excludes acquisition, integration, and transitional expenses; restructuring expense; and other expenses related to the Company's strategic assessment. Segment Adjusted EBITDA also excludes the operating losses of start-up branch locations that the Company has invested in organically rather than through acquisition. Segment Adjusted EBITDA is a measure of earnings that management monitors as an important indicator of operating and financial performance. The accounting policies of the operating and reportable segments are consistent with those described in the Company's summary of significant accounting policies.

Segment Reporting Information

(in thousands)

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Results of Operations:
Revenue:
Infusion Services - product revenue	$	150,559		$	108,557		$	300,583		$	215,360
Infusion Services - service revenue	5,606			2,416			9,959			4,667
Total Infusion Services revenue	156,165			110,973			310,542			220,027
Home Health Services - service revenue	18,228			16,860			36,169			33,571
PBM Services - service revenue	16,340			28,068			43,093			57,936
Total revenue	$	190,733		$	155,901		$	389,804		$	311,534
Adjusted EBITDA by Segment before corporate overhead:
Infusion Services	$	14,193		$	8,026		$	26,508		$	15,809
Home Health Services	1,097			1,075			1,980			2,155
PBM Services	4,920			6,364			11,119			12,462
Total Segment Adjusted EBITDA	20,210			15,465			39,607			30,426
Corporate overhead	(8,132		)	(6,458		)	(16,048		)	(13,040		)
Interest expense, net	(6,508		)	(6,639		)	(12,986		)	(13,208		)
Income tax (expense) benefit	(498		)	(364		)	(556		)	138
Depreciation	(2,570		)	(2,050		)	(5,029		)	(3,981		)
Amortization of intangibles	(1,710		)	(878		)	(3,792		)	(1,757		)
Stock-based compensation expense	(3,860		)	(1,745		)	(5,833		)	(2,711		)
Acquisition, integration, severance and other employee expenses	(3,512		)	(636		)	(8,135		)	(808		)
Restructuring and other expenses and investments	(1,737		)	(988		)	(3,015		)	(1,375		)
Loss from continuing operations, net of income taxes	$	(8,317	)	$	(4,293	)	$	(15,787	)	$	(6,316	)
Supplemental Operating Data
							June 30, 2013			December 31, 2012
Total Assets:
Infusion Services							$	534,571		$	438,623
Home Health Services							63,366			62,403
PBM Services							33,453			36,354
Corporate unallocated, including cash and cash equivalents							113,039			95,813
Assets associated with discontinued operations, not sold							2,283			9,183
Total							$	746,712		$	642,376